SCHEMBL32665022

SCHEMBL32665022

O=C(CCl)c1cccc(OS(=O)(=O)F)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STS P08842 7/20 0.47
ALDH1A1 P00352 4/20 0.46
GSK3B P49841 2/20 0.46
TRPA1 O75762 1/20 0.46
MAPK1 P28482 1/20 0.46
HIF1A Q16665 1/20 0.46
HSD11B1 P28845 1/20 0.43
ERCC5 P28715 1/20 0.40
FEN1 P39748 1/20 0.40
PPARG P37231 1/20 0.40
RAB9A P51151 3/20 0.38
MEN1 O00255 2/20 0.38
NPC1 O15118 2/20 0.38
MAPT P10636 2/20 0.38
KMT2A Q03164 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
NFKB1 P19838 1/20 0.38
STAT3 P40763 1/20 0.38
HTT P42858 1/20 0.38
NFKB2 Q00653 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32665549 0.84 GSK3B (0.50) STSGSK3BHSD11B1ERCC5FEN1
SCHEMBL31444709 0.80 AKR1C3 (0.58) STSPPARGKMT2A
SCHEMBL32665541 0.79 STS (0.51) STSALDH1A1RAB9AMEN1NPC1
SCHEMBL2379429 0.78 RAB9A (0.55) ALDH1A1MAPK1RAB9AMEN1NPC1
SCHEMBL2379240 0.77 CES2 (0.65) ALDH1A1GSK3BTRPA1MAPK1HIF1A
SCHEMBL2379136 0.76 KAT6A (0.52) ALDH1A1GSK3BTRPA1MAPK1HIF1A
SCHEMBL19568047 0.76 CA12 (0.50) STSRAB9AMEN1NPC1MAPT
SCHEMBL8548986 0.76 ERCC5 (0.67) ALDH1A1GSK3BTRPA1MAPK1HIF1A
SCHEMBL18507891 0.75 CA1 (0.60) STSPPARGMEN1KMT2A
SCHEMBL32665506 0.75 HTT (0.63) ALDH1A1MAPK1SMN1; SMN2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260021192-A1 PROTEINS HAVING A COVALENT WARHEAD TOPAZ THERAPEUTICS INC (US) 2026-01-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260021192-A1 PROTEINS HAVING A COVALENT WARHEAD RIOX2, ORC3, DCLRE1A STS 3493/4885ALDH1A1 3714/4885GSK3B 3967/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.